Published Data Registry

show all
TitleAuthorsJournalPublication year
DOI
PMID
HMGB1 as a Key Mediator of Immune Mechanisms in Ischemic Stroke.Singh V, Roth S, Veltkamp R, Liesz AAntioxidants & redox signaling2016
TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons.(Open Access) Schwenk BM, Hartmann H, (...), Edbauer DThe EMBO journal2016
C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins.(Open Access) Zhang YJ, Gendron TF, (...), Petrucelli LNature neuroscience2016
The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.(Open Access) Gijselinck I, Van Mossevelde S, (...), Van Broeckhoven CMolecular psychiatry2016
TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance.(Open Access) Xiang X, Werner G, (...), Haass CEMBO molecular medicine2016
Stroke research at the crossroads - where are we heading?(Open Access) Roth S, Liesz ASwiss medical weekly2016
Soluble Oligomers of PolyQ-Expanded Huntingtin Target a Multiplicity of Key Cellular Factors.(Open Access) Kim YE, Hosp F, (...), Hartl FUMolecular cell2016
Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA.(Open Access) Woerner AC, Frottin F, (...), Hipp MSScience (New York, N.Y.)2016
Reduced hnRNPA3 increases C9orf72 repeat RNA levels and dipeptide-repeat protein deposition.(Open Access) Mori K, Nihei Y, (...), Haass CEMBO reports2016
An amyloid-like cascade hypothesis for C9orf72 ALS/FTD.(Open Access) Edbauer D, Haass CCurrent opinion in neurobiology2016